Por: WPLG Local 10 Health December 07, 2022
WASHINGTON – Expedited drug approvals slowed this year as the Food and Drug Administration's controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency’s own leaders.With less than a month remaining in the year, the FDA’s drug center has granted 10 accelerated approvals — fewer than the tally in each of the last five years, when use of the program reached all-time highs.The... + full article
ABC News USA Business December 07, 2022
WASHINGTON -- Expedited drug approvals slowed this year as the Food and Drug Administration's controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency’s own leaders.With less than a month remaining in the year,... + más
Speedier drug approvals hit slowdown as FDA faces scrutiny | ABC News
Speedier drug approvals hit slowdown as FDA faces scrutiny | WPLG Local 10
ABC News USA Health December 07, 2022
Associated Press USA Politics December 07, 2022
WASHINGTON (AP) — Expedited drug approvals slowed this year as the Food and Drug Administration’s controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency’s own leaders.With less than a month remaining in the... + más
ABC News USA Health October 17, 2022
WASHINGTON -- The maker of the only U.S. drug intended to prevent premature births is making a last-ditch effort this week to keep its medication on the market, even as regulators insist that it doesn't work.A Food and Drug Administration meeting that opened Monday comes... + más
ALS drug wins FDA approval despite questionable data | ABC News
FDA pushes to remove pregnancy drug, company pushes back | WPLG Local 10
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | WPLG Local 10
WPLG Local 10 USA Politics September 30, 2022
WASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
Associated Press USA Science September 30, 2022
WASHINGTON (AP) — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration... + más
About iurex | Privacy Policy | Disclaimer |